trigger an antibody response, but did induce a response by cells of the immune system, Intermediate exposure induced both. Finally, cellular immune responses declined with post-exposure use of antibiotics, suggesting that the intervention impeded spore germination and implying that it may reduce the incidence of both subclinical and clinical B. anthracis infection.
In an accompanying editorial, James L. Hadler, MD, MPH, of the Infectious Diseases Section of the Connecticut Department of Public Health, commented that the study by Doolan and coworkers is "one of the few studies of the immune response to high-level, naturally occurring anthrax exposure in humans, and may be the first to describe cell-mediated responses to this pathogen." Dr. Hadler said that the study's data suggest that cell-mediated responses in B. anthracis infection may be more sensitive than antibody responses, and he recommended that future studies of anthrax vaccines investigate cellular immunity's role in inhibiting the pathogen.
Contact: Steve Baragona
Infectious Diseases Society of America 4-Jan-2007Page: 1 2 Related medicine news :1
. Anthrax detector developed2
. Anthrax treatments cost effectiveness shown in Stanford study3
. Many heart attack patients still not getting emergency clot-busting treatment4
. Moderate drinking lowers womens risk of heart attack5
. Sleep apnea increases risk of heart attack or death by 30 percent6
. SCAI highlights study using wireless technology to speed care of heart attack patients7
. Anxiety hikes risk of heart attack, death8
. Unfair treatment boosts heart attack risk9
. High-dose anticlotting drug cuts heart attack, death risk in half10
. Debate focuses on door-to-balloon time in heart attack treatment11
. Most young women dont recognize heart attack warning signs